PE Deals Logo
PE Deals UK M&A Brokers & VC
Back to Deals
Scan.com
Value £162,000,000

Scan.com

VC Funding
Series C £100m+
View

Summary

London-headquartered medical imaging infrastructure company Scan.com has successfully secured $220 million (£162 million) in combined Series C equity and growth debt financing to accelerate its nationwide US expansion and support M&A activities ahead of a potential stock market flotation.

Summary of transaction details:

  • Value: $220 million (£162 million) total financing package ($90 million / £66 million Series C equity round plus $130 million / £96 million in debt facilities).
  • Sector: Healthcare & Biotech / HealthTech / Medical Imaging.
  • Advisor / Capital Structure: Equity tranche led by French investment firm Noteus Partners; debt facilities provided by VerisFi Capital and Atempo Growth. Coincides with exploratory IPO discussions with the London Stock Exchange (LSE).
  • Key Entities: Target: Scan.com (Scan.com Limited); Lead Equity Investor: Noteus Partners; Debt Providers: VerisFi Capital, Atempo Growth; Co-Investors: Aviva (Aviva Investors), Concord Health Partners, YZR Capital, Oxford Capital; Key Founders: Charlie Bullock (CEO), Oliver Knight (COO), Joe Daniels (Head of UX), Dr. Khalid Latief, Jasper Nissim.
  • Location: London, UK (HQ) and New York, USA (US Operations Hub).

Note: Founded in 2017 originally as National MRI Scan by clinicians Dr. Khalid Latief and Jasper Nissim alongside Charlie Bullock, Oliver Knight, and Joe Daniels, Scan.com provides an integrated digital infrastructure network and API layer for medical diagnostics. The US medical imaging market exceeds $100 billion annually across roughly 600 million scans, yet approximately 85% of procedures remain coordinated through manual faxes and phone calls, resulting in weeks-long appointment backlogs, idle scanner capacity, and extreme price variance for identical procedures. Scan.com replaces static directories with a centralized two-way API integrating directly into electronic medical records (EMRs) and independent imaging scheduling software. The platform uses AI to match incoming referrals against live machine availability, transparent pricing, and specialized clinical sub-disciplines, automatically routing diagnostic imaging reports to subspecialty radiologists within 48 hours. Having scaled past a $165 million (£122 million) annualized run rate and served over 900,000 patients globally, Scan.com will deploy the $220m package to fund strategic acquisitions, expand US health plan and employer integrations, and scale its 80% US-based operational footprint while retaining UK corporate headquarters.

Noteus Partners

Lead Investor / Acquirer

Noteus Partners

Advising Broker

Undisclosed Firm

Original Source

View the original press release or news article describing this transaction in full.

Read Original Post

AI Insight Lenses

Pro

AI-generated analysis from four professional perspectives. Powered by PE Deals.

Sign in to unlock AI Lenses

Sign in

Sign in to submit corrections

Free to all registered users.